A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial

• Shinji L. Okitsu,

  Current address: Department of Immunology, The Scripps Research Institute, La Jolla, California, United States of America,

  Affiliation Molecular Immunology, Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Olivier Silvie,

  Current address: Department of Parasitology, Heidelberg University School of Medicine, Heidelberg, Germany

  Affiliation INSERM/UPMC UMR S U511, Immunobiologie Cellulaire et Moléculaire des Infections Parasitaires, Faculté de Médecine Pierre et Marie Curie, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France

  ⨯
• Nicole Westerfeld,

  Affiliation Pevion Biotech, Bern, Switzerland

  ⨯
• Marija Curcic,

  Affiliation Molecular Immunology, Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Andreas R. Kammer,

  Affiliation Pevion Biotech, Bern, Switzerland

  ⨯
• Markus S. Mueller,

  Affiliation Molecular Immunology, Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Robert W. Sauerwein,

  Affiliation Department of Medical Microbiology, University Medical Centre St Radboud, Nijmegen, The Netherlands

  ⨯
• John A. Robinson,

  Affiliation Institute of Organic Chemistry, University of Zurich, Zurich, Switzerland

  ⨯
• Blaise Genton,

  Affiliation Molecular Immunology, Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Dominique Mazier,

  Affiliation INSERM/UPMC UMR S U511, Immunobiologie Cellulaire et Moléculaire des Infections Parasitaires, Faculté de Médecine Pierre et Marie Curie, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France

  ⨯
• Rinaldo Zurbriggen,

  Affiliation Pevion Biotech, Bern, Switzerland

  ⨯
• Gerd Pluschke

  *To whom correspondence should be addressed. E-mail: Gerd.Pluschke@unibas.ch

  Affiliation Molecular Immunology, Swiss Tropical Institute, Basel, Switzerland

  ⨯